Paclitaxel Injection
Product Images NDC 46708-621

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Paclitaxel (NDC 46708-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paclitaxel-1figure (Paclitaxel 1figure)

A survival curve chart comparing the proportion surviving over a period of up to 5 years for two groups labeled Cc and Tc. The chart includes data on the number at risk over time and a summary inset with the number of subjects (N), number of events, and hazard ratio with confidence interval for each group.*

FDA Label Image

Paclitaxel-2figure (Paclitaxel 2figure)

A survival curve graph depicting proportion surviving over five years for two groups labeled Cc and Tc. The y-axis shows proportion surviving from 0 to 1; the x-axis shows years from 0 to 5. The inset provides sample sizes (N), number of events, and a hazard ratio with confidence interval for comparison between groups.*

FDA Label Image

Paclitaxel-3figure (Paclitaxel 3figure)

A survival curve chart showing the proportion of patients disease-free over a period of up to 4 years. The chart compares two groups labeled AC and AC+T, with AC+T showing a slightly higher disease-free proportion. The x-axis represents years, and the y-axis represents the proportion disease-free. A data table within the chart provides patient numbers, event counts, and hazard ratio (HR) with confidence interval (CI).*

FDA Label Image

Paclitaxel-4figure (Paclitaxel 4figure)

A survival curve chart comparing the proportion surviving over a period of 4 years between two groups labeled AC and AC+T. The chart includes a table of sample sizes, number of events, and hazard ratio with confidence interval, plus the number of individuals at risk at yearly intervals for both groups.*

FDA Label Image

Paclitaxel-5figure (Paclitaxel 5figure)

A survival curve chart depicting the proportion of patients disease-free over a period of 0 to 4 years comparing two treatment groups labeled AC and AC+T. The chart shows AC+T with a higher disease-free proportion over time. A table inset provides statistical data including the number of patients (N), number of events, hazard ratio (HR), and confidence interval (CI) for both groups, along with the number of patients at risk at yearly intervals.*

FDA Label Image

Paclitaxel-6figure (Paclitaxel 6figure)

A Kaplan-Meier curve chart showing the proportion of disease-free patients over a 4-year period comparing two groups labeled AC and AC+T. The graph includes a table with the number of subjects (N), number of events, hazard ratio (HR), and 95% confidence interval (CI), as well as the number of patients at risk over time for each group.*

FDA Label Image

Paclitaxel-7figure (Paclitaxel 7figure)

A survival curve graph depicting the proportion of patients disease-free over four years, comparing two treatment groups labeled AC and AC+T. The plot shows a gradual decline in disease-free proportion for both groups, with AC+T slightly higher than AC. An inset table provides sample sizes, number of events, hazard ratio (HR 0.83), and 95% confidence interval (0.67-1.01) for each group.*

FDA Label Image

Paclitaxel-8figure (Paclitaxel 8figure)

A survival curve chart showing the proportion of patients disease-free over four years for two groups labeled AC and AC+T. The plot includes a table with numbers of events, hazard ratio (HR), and 95% confidence interval (CI). Below the x-axis, the number of patients at risk is listed for both groups across the years.*

FDA Label Image

Paclitaxel-carton-100mg (Paclitaxel Carton 100mg)

Packaging label for Paclitaxel Injection, USP 6 mg/mL by Alembic Pharmaceuticals Limited. The label indicates a 100 mg/16.7 mL concentration in a multiple dose vial. It includes warnings about dilution required prior to intravenous infusion, cytotoxic agent handling, and storage instructions. The label also shows manufacturer details and barcode.*

FDA Label Image

Paclitaxel-carton-300mg (Paclitaxel Carton 300mg)

Packaging label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) injection by Alembic Pharmaceuticals Limited. The label includes warnings about cytotoxicity, dilution requirements prior to intravenous infusion, and storage instructions. The product is supplied as a 50 mL multiple dose vial, intended for intravenous use only.*

FDA Label Image

Paclitaxel-carton-30mg (Paclitaxel Carton 30mg)

Packaging label for Paclitaxel Injection, USP, 30 mg/5 mL (6 mg/mL) by Alembic Pharmaceuticals Limited. The label indicates it is a semisynthetic intravenous injection in a 1 x 5 mL multiple dose vial. It includes dilution cautions, storage instructions, and safety warnings such as cytotoxic agent handling precautions. The carton dimensions are approximately 35x35x65 mm.*

FDA Label Image

Paclitaxel-str (Paclitaxel Str)

Chemical structure diagram of Paclitaxel showing its molecular framework with multiple ring systems, hydroxyl groups, and ester functionalities.*

FDA Label Image

Paclitaxel-vial-100mg (Paclitaxel Vial 100mg)

Label for Paclitaxel Injection, USP 6 mg/mL by Alembic Pharmaceuticals Limited. The label states 100 mg/16.7 mL in a 16.7 mL multiple dose vial. It includes warnings such as "Dilution Required Prior to Intravenous Infusion" and "Cytotoxic Agent." The label lists inactive ingredients and storage instructions, with a bar code and NDC 46708-621-17.*

FDA Label Image

Paclitaxel-vial-300mg (Paclitaxel Vial 300mg)

Label for Paclitaxel Injection, USP 300 mg/50 mL (6 mg/mL) intravenous injection by Alembic Pharmaceuticals Limited. The label includes active ingredient concentrations, usage cautions such as wearing gloves and dilution requirements, storage conditions, NDC 46708-622-50, manufacturing details, and a barcode. It specifies a 50 mL multiple dose vial and warns that Paclitaxel is a cytotoxic agent.*

FDA Label Image

Paclitaxel-vial-30mg (Paclitaxel Vial 30mg)

Label for Paclitaxel Injection, USP, 6 mg/mL concentration supplied as 30 mg/5 mL in a 5 mL multiple dose vial. The label indicates it is a semisynthetic product manufactured by Alembic Pharmaceuticals Limited, Gujarat, India. It includes caution and warning statements regarding dilution and cytotoxicity.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.